Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. Jeong JH, Chokkakula S, Min SC, Kim BK, et al. Antiviral Res 2022;208:105430.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jeong JH, Chokkakula S, Min SC, Kim BK, et al. Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. Antiviral Res 2022;208:105430.
PMID: 36209984